Fluidigm (FLDM) Well Positioned for Growth in Single Sell, Leerink Partners Says

Leerink Partners analyst Dan Leonard reiterated an Outperform rating and $45 price target on Fluidigm Corporation (NASDAQ: FLDM), saying single cell signs still largely bullish for FLDM.

Leonard commented, "Following recent due diligence, which includes a MEDACorp survey, we continue to believe FLDM is well positioned to benefit from the growth in single cell analysis. While current market concerns over the position of Biomark (~40% of FLDM’s 2014e revenue) are valid, we believe FLDM’s current stock price represents an attractive entry point in front of several new product launches. We reiterate our Outperform rating and consider FLDM one of our top small cap picks."

For an analyst ratings summary and ratings history on Fluidigm Corporation click here. For more ratings news on Fluidigm Corporation click here.

Shares of Fluidigm Corporation closed at $25.03 yesterday.

You May Also Be Interested In

• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
• Amphenol (APH) PT Raised to $130 at Evercore ISI, Remains Top Pick
• BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'